Mesco Pharmaceuticals Ltd

BSE : MESCOPHARM10 Jan 2022
Pharmaceuticals
₹
0.00 (0.00%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
BUY
SELL
To Invest in Mesco Pharmaceuticals Ltd
Mesco Pharmaceuticals Ltd
Pharmaceuticals
BSE : MESCOPHARM10 Jan 2022
₹
0.00 (0.00%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All
No Data Found

Mesco Pharmaceuticals Ltd - Share Price & Details

Traded Volume
₹
Market Cap(Cr)
Avg Traded Price
1 Year return
-39.39%
Upper Circuit
Lower Circuit
P/E TTM
0
P/B Ratio
-0.88
Traded Value(Cr)
0.00
EPS TTM
0
Book value
Dividend
0.00%

Invest in Mesco Pharmaceuticals Ltd at ZERO Brokerage for 30 days

Price Performance

0.00 %
1 Wk
0.00 %
1 M
-2.37 %
3 M
-39.39 %
1 Y
0.00 %
YTD

Traded Volume Movement

Technical Details

Support 3
0
Support 2
0
Support 1
0
Pivot Point :
0
Resistance 1
0
Resistance 2
0
Resistance 3
0

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Mesco Pharmaceuticals Ltd
₹4.54(0.00/0.00%)
4.54+0.009.23-39.390.00-0.88
Bliss GVS Pharma Ltd
₹149.70(-3.90/-2.54%)
149.70-3.901,577.3922.8619.441.54
Astrazeneca Pharma India Ltd
₹7,639.45(+45.90/0.60%)
7,639.45+45.9019,098.6312.94148.3728.11
Amrutanjan Health Care Ltd
₹659.70(-11.10/-1.65%)
659.70-11.101,907.2311.8340.136.40
Abbott India Ltd
₹29,796.40(+694.45/2.39%)
29,796.40+694.4563,317.353.7547.4517.98
Ambalal Sarabhai Enterprises Ltd
₹53.24(+1.69/3.28%)
53.24+1.69408.00-21.8746.309.05

About Mesco Pharmaceuticals Ltd

Mesco Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 9.23 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. 0 crores for the quarter ended December 2018. The company management includes , Dushyant Kumar Singh,N S Parameshwaran,Hawa Singh Chahar,Dhruv Singh (Mesco Pharmaceuticals Ltd) among others.
Chairman
Registered office
Upper Kesalton,Tallital,Nainital,Uttar Pradesh,263001
FAX :
Background
Incorporation Year1986
Face Value₹10
Market Lot1

Latest News

Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday

The Indian stock market ended lower for the third straight session, with the Nifty 50 index down 43 points at 23,559, amid weak global market sentiments. Sumeet Bagadia, Executive Director at Choice Broking, recommends buying 📌HDFC Life, 📌UltraTech Cement, and 📌Tech Mahindra, with targets of ₹700, ₹12,800, and ₹1,875, respectively.
08 Feb 2025 | 03:11 PM

These smallcaps have surged up to 26% as broader indices see muted gains

The broader indices performed in line with the main indices, which witnessed volatility amid mixed quarterly earnings, continued FII selling, mixed global markets due to uncertain tariff policies by the US President and rate cut by RBI in almost five years. BSE Smallcap index ended marginally in the green, breaking a 4-week losing streak, while BSE Midcap and Largecap indices ended higher.
08 Feb 2025 | 03:03 PM

Zaggle ups FY25 revenue guidance to 58-63%, profit increases 33% YoY

Zaggle Prepaid Ocean Services reported a 69% year-on-year surge in revenue, reaching  ₹336.4 crore in Q3FY25. Net profit grew to  ₹20.2 crore during the quarter, marking a 33% year-on-year increase. The revenue surge was driven by a 54% increase in programme fees from its expanded prepaid and credit card portfolio and an 86% jump in Propel revenue, fuelled by heightened festive season spending.
08 Feb 2025 | 12:11 PM

BHEL secures ₹8,000 crore thermal power project from Mahagenco

State-owned Bharat Heavy Electricals Ltd. (BHEL) has received a Letter of Award (LoA) worth approximately ₹8,000 crore from Maharashtra State Power Generation Company Ltd (Mahagenco). The LoA is for 2x660 MW BTG package of Koradi Thermal Power Station, the company said in an exchange filing. The BTG package includes supply of equipment, erection and commissioning and civil works.
08 Feb 2025 | 12:11 PM

Zaggle ups FY25 revenue guidance to 58-63%, profit increases 33% YoY

Zaggle Prepaid Ocean Services reported a 69% year-on-year surge in revenue, reaching  ₹336.4 crore in Q3FY25. Net profit grew to  ₹20.2 crore during the quarter, marking a 33% year-on-year increase. The revenue surge was driven by a 54% increase in programme fees from its expanded prepaid and credit card portfolio and an 86% jump in Propel revenue, fuelled by heightened festive season spending.
08 Feb 2025 | 12:11 PM
view more news

How to buy Mesco Pharmaceuticals Ltd shares on nse?

To buy Mesco Pharmaceuticals Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Mesco Pharmaceuticals Ltd share price today?

The Mesco Pharmaceuticals Ltd shares price on nse is Rs.4.54 today.

What is the market cap of Mesco Pharmaceuticals Ltd shares on BSE ?

The company has a market capitalization of Rs.9.23Cr

What is the PE & PB ratio of Mesco Pharmaceuticals Ltd shares ?

PE is 0 and PB is -0.88

What is the 52 Week High and Low of Mesco Pharmaceuticals Ltd shares?

Mesco Pharmaceuticals Ltd stock price high: Rs.4.54 Mesco Pharmaceuticals Ltd stock price low: Rs.0
BUY
SELL